Endava (NYSE:DAVA) Stock Price Down 5.2% After Analyst Downgrade
Endava (NYSE:DAVA) shares fell 5.2% after Guggenheim downgraded its price target. The stock traded as low as $40.58, with a last trade at $40.71, and saw a 44% drop in trading volume. Other analysts, including TD Cowen and Wedbush, also adjusted their price targets while maintaining buy ratings. Currently, Endava has a consensus rating of "Moderate Buy" with a price target of $41.01. Institutional investors hold 62.23% of the stock, which has a market cap of $1.83 billion and a PE ratio of 35.93.
Endava plc (NYSE:DAVA - Get Free Report) was down 5.2% during mid-day trading on Monday after Guggenheim lowered their price target on the stock from $55.00 to $45.00. Guggenheim currently has a buy rating on the stock. Endava traded as low as $31.58 and last traded at $31.71. Approximately 290,165 shares were traded during mid-day trading, a decline of 44% from the average daily volume of 515,764 shares. The stock had previously closed at $33.45.
- Globant Is an Emerging AI Play That’s Expanding Its Footprint
A number of other analysts have also weighed in on DAVA. TD Cowen lowered their target price on Endava from $46.00 to $42.00 and set a "buy" rating for the company in a report on Friday, May 24th. Wedbush reduced their price target on Endava from $65.00 to $50.00 and set an "outperform" rating on the stock in a research report on Thursday, May 23rd. JPMorgan Chase & Co. upped their price target on Endava from $41.00 to $47.00 and gave the stock an "overweight" rating in a research report on Friday, September 6th. Needham & Company LLC reduced their price target on Endava from $50.00 to $42.00 and set a "buy" rating on the stock in a research report on Friday, May 24th. Finally, Redburn Atlantic started coverage on Endava in a research report on Friday, May 24th. They issued a "neutral" rating and a $33.10 target price on the stock. Three equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus price target of $46.01.
View Our Latest Research Report on Endava
Institutional Investors Weigh In On Endava
- Endava Trading Higher After Topping Q4 Consensus Views
Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Assetmark Inc. boosted its stake in shares of Endava by 47.8% during the 4th quarter. Assetmark Inc. now owns 510 shares of the company's stock worth $40,000 after acquiring an additional 165 shares in the last quarter. Headlands Technologies LLC purchased a new position in Endava in the 1st quarter valued at about $49,000. Principal Securities Inc. purchased a new position in Endava in the 4th quarter valued at about $99,000. Quadrant Capital Group LLC lifted its stake in Endava by 34.8% in the 4th quarter. Quadrant Capital Group LLC now owns 1,424 shares of the company's stock valued at $111,000 after buying an additional 368 shares in the last quarter. Finally, Wallace Advisory Group LLC purchased a new position in Endava in the 1st quarter valued at about $126,000. 62.23% of the stock is owned by institutional investors and hedge funds.
Endava Stock Performance
The stock has a market capitalization of $1.83 billion, a PE ratio of 35.93 and a beta of 1.22. The stock's 50 day moving average is $30.65 and its two-hundred day moving average is $31.21.
Endava Company Profile
(Get Free Report)Endava plc provides technology services for clients in the consumer products, healthcare, mobility, and retail verticals in North America, Europe, the United Kingdom, and internationally. It offers ideation and production services in the payments and financial services, telecommunications, media, and technology verticals; and business analysis, data analytics, program management, digital product strategy, private equity value enhancement, IT strategy, architecture, extended reality, machine learning and artificial intelligence, product design, and user experience and visual design services.
Recommended Stories
- Five stocks we like better than Endava
- Insider Trades May Not Tell You What You Think
- Palo Alto Analysts Drive it to New Highs: 50% Upside Is Possible
- Stock Splits, Do They Really Impact Investors?
- Roblox's Growth Beyond Kids: Stock Set for Major Moves
- What is the Shanghai Stock Exchange Composite Index?
- 5 Oversold Stocks to Buy Right Now
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
→ Ex-CIA Advisor: “This is How Kamala will Rig the Election” (From Paradigm Press) (Ad)
Should you invest $1,000 in Endava right now?
Before you consider Endava, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Endava wasn't on the list.
While Endava currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
